Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
HER2-
.
Show all posts
Showing posts with label
HER2-
.
Show all posts
Thursday, October 30, 2025
FDA Approves Inluriyo (imlunestrant) for Adults with ER+, HER2-, ESR1-Mutated Advanced or Metastatic Breast Cancer
›
Eli Lilly and Company (NYSE: LLY) announced the U.S. Food and Drug Administration (FDA) approval of Inluriyo (imlunestrant, 200 mg tablet...
›
Home
View web version
